Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
暂无分享,去创建一个
M. Kattan | H. Hricak | P. Scardino | V. Reuter | A. Shukla-Dave | J. Koutcher | K. Zakian | S. Eberhardt | K. Sircar | S. Kleinman | M. Muruganandham
[1] M. Heesters,et al. Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy , 1993, Journal of Neuro-Oncology.
[2] Saroja Adusumilli,et al. Magnetic resonance imaging of prostate cancer. , 2002, Seminars in urologic oncology.
[3] O. Hélénon,et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. , 2002, Radiology.
[4] Jelle O. Barentsz,et al. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis , 2002, European Radiology.
[5] L. Molinier,et al. Assessment of the risk of positive surgical margins with pelvic phased-array magnetic resonance imaging in patients with clinically localized prostate cancer: a prospective study. , 2001, Urology.
[6] Tapio Vehmas,et al. PROSTATIC MR IMAGING , 2001 .
[7] K. Taari,et al. Prostatic MR imaging: Accuracy in differentiating cancer from other prostatic disorders , 2001, Acta radiologica.
[8] M. Terris,et al. Critical evaluation of the current indications for transition zone biopsies. , 2001, Urology.
[9] T. Stamey,et al. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. , 2000, The Journal of urology.
[10] H. Shimizu,et al. Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. , 2000, AJNR. American journal of neuroradiology.
[11] J. Kurhanewicz,et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.
[12] H. Hricak,et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging , 2000, Magnetic resonance in medicine.
[13] M. Sheridan,et al. The role of endorectal coil MRI in patient selection and treatment planning for prostate seed implants , 2000 .
[14] J Kurhanewicz,et al. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.
[15] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[16] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[17] G P Liney,et al. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd‐DTPA‐enhanced MR imaging and histopathology , 1999, Journal of magnetic resonance imaging : JMRI.
[18] J Kurhanewicz,et al. Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. , 1998, Radiology.
[19] S B Malkowicz,et al. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. , 1998, Urology.
[20] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[21] M. van der Graaf,et al. Proton MR spectroscopy of the normal human prostate with an endorectal coil and a double spin‐echo pulse sequence , 1997, Magnetic resonance in medicine.
[22] J. McNeal,et al. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. , 1996, Urology.
[23] S. Blackband,et al. Quantification of citrate concentration in the prostate by proton magnetic resonance spectroscopy: Zonal and age‐related differences , 1996, Magnetic resonance in medicine.
[24] P. Carroll,et al. Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. , 1996, Radiology.
[25] P. Carroll,et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.
[26] B L Miller,et al. Analysis of brain tumors using 1H magnetic resonance spectroscopy. , 1995, Surgical neurology.
[27] J. Saunders,et al. One-Dimensional Phosphorus-31 Chemical Shift Imaging of Human Brain Tumors , 1995, Investigative radiology.
[28] Bruno Alfano,et al. 1H MR Spectroscopy in Patients with Metastatic Brain Tumors: A Multicenter Study , 1995, Magnetic resonance in medicine.
[29] S. Nelson,et al. Surface coil MR imaging of the human brain with an analytic reception profile correction , 1995, Journal of magnetic resonance imaging : JMRI.
[30] J Kurhanewicz,et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.
[31] A. Heerschap,et al. Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. , 1993, The Journal of urology.
[32] R E Lenkinski,et al. Current role of MR imaging in the staging of adenocarcinoma of the prostate. , 1993, Radiology.
[33] J. Mohler,et al. In vitro high resolution 1h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma , 1993, Magnetic resonance in medicine.
[34] T. Stamey,et al. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. , 1993, The Journal of urology.
[35] J. Kurhanewicz,et al. Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study , 1993, Magnetic resonance in medicine.
[36] F. Schick,et al. Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T , 1993, Magnetic resonance in medicine.
[37] J A Frank,et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. , 1992, Radiology.
[38] J. Kurhanewicz,et al. Phosphorus metabolite characterization of human prostatic adenocarcinoma in a nude mouse model by 31P magnetic resonance spectroscopy and high pressure liquid chromatography , 1992, NMR in biomedicine.
[39] A. Fowler,et al. Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR , 1992, Magnetic resonance in medicine.
[40] M. Leach,et al. The phosphocholine and glycerophosphocholine content of an oestrogen-sensitive rat mammary tumour correlates strongly with growth rate. , 1991, British Journal of Cancer.
[41] P. Scardino,et al. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate. , 1991, The Journal of urology.
[42] J. Kurhanewicz,et al. Characterization of prostate cancer, benign prostatic hyperplasia and normal prostates using transrectal 31phosphorus magnetic resonance spectroscopy: a preliminary report. , 1991, The Journal of urology.
[43] D. Ballon,et al. 31P NMR spectra of extremity sarcomas: Diversity of metabolic profiles and changes in response to chemotherapy , 1990, Magnetic resonance in medicine.
[44] M. Dewhirst,et al. Soft-tissue sarcomas: MR imaging and MR spectroscopy for prognosis and therapy monitoring. Work in progress. , 1990, Radiology.
[45] L Axel,et al. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. , 1989, Radiology.
[46] H. Bruhn,et al. Localized high‐resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo , 1989, Magnetic resonance in medicine.
[47] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[48] U. Schmiedl,et al. MR Characteristics of Prostatic Carcinoma and Benign Prostatic Hyperplasia at 1.5 T , 1988, Journal of computer assisted tomography.
[49] J. S. Cohen,et al. Phospholipid metabolism in cancer cells monitored by 31P NMR spectroscopy. , 1987, The Journal of biological chemistry.
[50] K. Uğurbil,et al. NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. A. Groeneveld,et al. Practical Nonparametric Statistics (2nd ed). , 1981 .
[52] W. J. Conover,et al. Practical Nonparametric Statistics , 1972 .